| Lastest Insider Transactions Of Attovia Therapeutics, Inc. ( ATTO ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| ATTO | Attovia Therapeutics, Inc. | WALSH COLIN | Directior | 2026-08-05 | Buy | 585,000 | 17.58 | 10,285,000 | 2026-08-13 21:52:51 |
| ATTO | Attovia Therapeutics, Inc. | WALSH COLIN | Directior | 2026-08-05 | Sell | 105,807 | 21.28 | 2,251,658 | 2026-08-13 21:52:51 |
| ATTO | Attovia Therapeutics, Inc. | GOLDMAN SACHS GROUP INC | | 2026-08-05 | Buy | 585,000 | 17.58 | 10,285,000 | 2026-08-13 21:51:50 |
| ATTO | Attovia Therapeutics, Inc. | GOLDMAN SACHS GROUP INC | | 2026-08-05 | Sell | 105,807 | 21.28 | 2,251,658 | 2026-08-13 21:51:50 |
| ATTO | Attovia Therapeutics, Inc. | venBio Global Strategic Fund IV, L.P. | 10% Owner | 2026-08-06 | Buy | 382,352 | 17.00 | 6,499,984 | 2026-08-10 16:12:09 |
| ATTO | Attovia Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | 2026-08-06 | Buy | 600,000 | 17.00 | 10,200,000 | 2026-08-07 21:47:17 |
| ATTO | Attovia Therapeutics, Inc. | Sanofi | 10% Owner | 2026-08-06 | Buy | 300,000 | 17.00 | 5,100,000 | 2026-08-07 15:45:54 |
| ATTO | Attovia Therapeutics, Inc. | Frazier Life Sciences XI, L.P. | 10% Owner | 2026-08-06 | Buy | 588,235 | 17.00 | 9,999,995 | 2026-08-06 17:35:51 |
